Brief: Oncolytics Biotech Reports Third Quarter Financial Results
07/11/2022 14:35
Nov 7 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND RECENT OPERATIONAL HIGHLIGHTS
* ONCOLYTICS BIOTECH INC Q3 LOSS PER SHARE C$0.08
* ONCOLYTICS BIOTECH - $32.4 MILLION IN CASH AND CASH
EQUIVALENTS
AS OF SEPTEMBER 30, 2022 PROVIDES PROJECTED RUNWAY THROUGH KEY
MILESTONES TO END OF 2023
Source text for Eikon: ID:nCNWvKtc1a
Further company coverage: ONC.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer